Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
FATE THERAPEUTICS INC | Chief Medical Officer | Common Stock | 141K | $615K | $4.37 | Apr 18, 2023 | Direct |
CytomX Therapeutics, Inc. | Chief Medical Officer | Performance Stock Units (PSUs) | 75K | $104K | $1.38 | Jan 18, 2024 | Direct |
CytomX Therapeutics, Inc. | Chief Medical Officer | Common Stock | 26.3K | $36.2K | $1.38 | Jan 18, 2024 | Direct |
CytomX Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 123K | Jan 18, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTMX | CytomX Therapeutics, Inc. | Jan 18, 2024 | 3 | $0 | 4 | Jan 19, 2024 | Chief Medical Officer |
CTMX | CytomX Therapeutics, Inc. | Jul 19, 2023 | 1 | $0 | 4 | Jul 20, 2023 | Chief Medical Officer |
CTMX | CytomX Therapeutics, Inc. | Jul 19, 2023 | 0 | $0 | 3 | Jul 20, 2023 | Chief Medical Officer |
FATE | FATE THERAPEUTICS INC | Apr 18, 2023 | 2 | -$16.6K | 4 | Apr 19, 2023 | Chief Medical Officer |
FATE | FATE THERAPEUTICS INC | Feb 6, 2023 | 1 | $0 | 4 | Feb 7, 2023 | Chief Medical Officer |
FATE | FATE THERAPEUTICS INC | Jan 10, 2023 | 1 | -$41K | 4 | Jan 11, 2023 | Chief Medical Officer |
FATE | FATE THERAPEUTICS INC | Apr 19, 2022 | 1 | -$144K | 4 | Apr 21, 2022 | Chief Medical Officer |
FATE | FATE THERAPEUTICS INC | Jan 25, 2022 | 2 | $0 | 4 | Jan 27, 2022 | Chief Medical Officer |
FATE | FATE THERAPEUTICS INC | Jan 11, 2022 | 2 | -$192K | 4 | Jan 13, 2022 | Senior VP Clinical Development |
FATE | FATE THERAPEUTICS INC | Dec 10, 2021 | 9 | -$264K | 4 | Dec 13, 2021 | Senior VP Clinical Development |
FATE | FATE THERAPEUTICS INC | Nov 19, 2021 | 1 | $0 | 4 | Nov 22, 2021 | Senior VP Clinical Development |